NCT00728091View on ClinicalTrials.gov

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
HyponatremiaInappropriate ADH Syndrome
Interventions
DRUG

Satavaptan

tablets

DRUG

placebo

tablets

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY